pharmaceutical investing Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
medical device investing Helius Medical Technologies Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants